Ovid Therapeutics Inc.

NASDAQ
OVID
Stock
Yield per half year: -56.37%
Dividend yield: 0%
Sector: Healthcare

Ovid Therapeutics Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0.1595 63.23 -99.75% -1.57 -110.19%
P/S 119.9 32.67 267.03%
P/BV 0.9947 18.83 -94.72%
P/FCF -4.89 -11.83 -58.68%
Ev/Ebitda -0.91 274.42 -100.33%
Ev/S 99.5 21.54 361.92%
Ev/FCF -1.01 -15.84 -93.65%
E/P -0.0965 0.0188 -612.15%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-10933.75 -10.92 100015.01% -8027.88 +36.2%
ROE -33.88 14.17 -339.12%
ROA -22.38 1.18 -1993.82%
ROIC -31.03 7.63 -506.45%
ROS -4670.14 -22.82 20367.72%
ROCE -91.6 6.29 -1556.52%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.2384 1.27 -118.76% -0.2649 -9.99%
Nеt Debt/Ebitda 0.1866 -10.2 -101.83%
Debt/Ratio 0.1601 0.1978 -19.06%
Debt/Equity 0.3509 1.3 -73.11%
Debt/Net Income -0.5582 2.46 -122.66%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5277 -100% 0 0%
Number of years of dividend growth 0 0.9474 -100%
DSI 0 0.2279 -100%
Average dividend growth 0 1.14 -100%
Average percentage for 5 years 0 0.554 -100%
Average percentage for payments 0 64.78 -100%
Difference from average difference in sector -0.5277

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-95.51 68.41 -239.61%
Growth impulse Ebitda in 5 years -23.97 33.15 -172.31%
Growth impulse Net Income in 5 years -67.08 -6.56 922.56%
Growth impulse FCF in 5 years 7.74 27.51 -71.86%
Growth impulse EPS in 5 years -72.79 24.03 -402.91%
IP Score
3.07/10

Similar companies

Illumina

Incyte

Amarin

ImmunoGen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription